Pathogenic Role of Diabetes-Induced Overexpression of Kallistatin in Corneal Wound Healing Deficiency Through Inhibition of Canonical Wnt Signaling is a research paper published in Diabetes (2022). On theSindex it has a DataRank of 0.977. It has been cited 30 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0.462
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
NEI NIH HHS
Grant: P30 EY021725
NEI NIH HHS
Grant: R01 EY019309
NEI NIH HHS
Grant: R01 EY028949
NEI NIH HHS
Grant: R01 EY032930
NEI NIH HHS
Grant: R01 EY032931
NEI NIH HHS
Grant: R01 EY012231
NIGMS NIH HHS
Grant: P30 GM122744
National Institutes of Health
Grant: 2P30EY021725-06
P30-Center Core Grant for Vision Research
National Institutes of Health
Grant: 7R01EY028949-04
A Novel Pathogenic Pathway for Diabetic Keratopathy
National Institutes of Health
Grant: 5P30GM122744-03
Mentoring Diabetes Research in Oklahoma
National Institutes of Health
Grant: 7R01EY032930-02
Studies of retinyl ester hydrolase in the visual cycle
National Institutes of Health
Grant: 5R01EY032931-06
Dysregulation of Wnt signaling in subretinal fibrosis in AMD
National Institutes of Health
Grant: 5R01EY012231-10
Studies of RPE65
National Institutes of Health
Grant: 5R01EY019309-10
A new pathogenic mechanism for diabetic retinopathy
FWCI
2.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Endothelial β-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9
Additional file 1 of Endothelial β-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9
Additional file 2 of Endothelial β-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9
Additional file 2 of Endothelial β-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9